Pomerantz has earned a reputation for prosecuting complex antitrust and consumer class actions with vigor, innovation, and success. The Firm’s Antitrust practice group has recovered billions of dollars for shareholders. Time and again, Pomerantz has protected the free-market system from anticompetitive conduct such as price fixing, monopolization, exclusive territorial division, pernicious pharmaceutical conduct, and false advertising.

Through advocacy that has spanned across diverse product markets, the Pomerantz Antitrust practice group has demonstrated the versatility to prosecute class actions on any terrain. The Firm has spearheaded efforts to challenge harmful anticompetitive conduct by pharmaceutical companies, financial institutions, major league sports and other industries.

From fighting antitrust behavior by NASDAQ market-makers to challenging artificially inflated prescription drug prices and scoring victories over Major League Baseball and the National Hockey League on behalf of fans over geographic blackouts, Pomerantz’s cases illustrate the expertise and commitment that the Firm’s Antitrust practice group devotes to prosecuting egregious anticompetitive conduct, no matter where it is found.